The  Food and Drug Administration is issuing strong new warnings that the combined use of opioid medications and benzodiazepines, a class of anti-anxiety medications better known by such commercial names as Xanax and Ativan, can dangerously suppress breathing and cause coma or death.

The drug safety agency is recommending that physicians take extra care in prescribing medication regimens that mix the two classes of drugs. And it is alerting people who use — or abuse — such drugs to the “serious risks” of taking them together.

By: Dr. Leana Wen

In thousands of conversations with community members, businesses, grassroots organizations, and elected leaders across Baltimore, I have seen how our City continues to wrestle with deeply-rooted issues of poverty, racial inequality, and structural racism.

​Here in Baltimore, there are neighborhoods just blocks apart where the life expectancy differs by 20 years. We have made significant strides in reducing infant mortality, and yet Black babies continue to die at twice the rate of White babies. Homicide continues to be the leading cause of death among 15-24 year olds in the city – more than 90 percent of homicide victims in 2016 have been Black.

The Food and Drug Administration, alarmed that increasing numbers of Americans are combining opioid painkillers and benzodiazepines, said Wednesday that it will require tough new warnings on the product labels that spell out the serious dangers of mixing the drugs.

The agency said it will require “boxed warnings” — its strongest category — on 389 separate products and will mandate the warning on opioid-containing cough medications. The new language will list the hazards of using the medications in tandem, which include extreme sleepiness, respiratory depression, coma and even death.